The external ventricular drain market has seen considerable growth due to a variety of factors.
• The external ventricular drain market has grown rapidly in recent years. It will increase from $4.71 billion in 2024 to $5.02 billion in 2025, at a CAGR of 6.7%.
The historical growth is due to advancements in neurosurgery, a rise in traumatic brain injuries (TBI), the aging population, and regulatory support.
The external ventricular drain market is expected to maintain its strong growth trajectory in upcoming years.
• The external ventricular drain market is projected to reach $6.46 billion by 2029 with a CAGR of 6.5%.
Growth drivers include the rise in neurological disorders, demand for minimally invasive procedures, healthcare infrastructure expansion, and a focus on patient outcomes. Trends include minimally invasive techniques, advanced monitoring technologies, antimicrobial drain innovations, and emerging market expansion.
The increasing incidence of traumatic brain injuries (TBI) is expected to drive the growth of the external ventricular drain market. TBIs, often caused by sports, vehicle accidents, or falls, result in elevated intracranial pressure that can be mitigated by external ventricular drains. In May 2024, Florida's Department of Health reported an increase in TBI-related deaths, further highlighting the demand for such medical devices.
The external ventricular drain market covered in this report is segmented –
1) By Product: External Ventricular Drainage Set, Accessories
2) By Application: Traumatic Brain Injury, Intracranial Hemorrhage, Hydrocephalus, Other Applications
3) By End-User: Hospitals, Specialty Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) External Ventricular Drainage Set: Standard External Ventricular Drainage Set, Adjustable External Ventricular Drainage Set, Continuous External Ventricular Drainage Set
2) Accessories: Catheters, Pressure Monitoring Devices, Drainage Bags, Connecting Tubes
Companies in the external ventricular drain market are focused on advanced fluid management solutions to treat intracranial bleeding more effectively. These solutions incorporate features like real-time monitoring and active irrigation to improve drainage and treatment outcomes. For instance, in February 2022, IRRAS Inc., a US-based company, launched the IRRAflow system, an advanced external ventricular drain that uses automated irrigation to enhance drainage and prevent blockages, improving the treatment of critically ill patients with intracranial bleeding.
Major companies operating in the external ventricular drain market are:
• Medtronic Plc
• B. Braun SE
• Terumo Corporation
• Getinge AB
• Elekta AB
• Integra LifeSciences
• ABIOMED
• Raumedic AG
• Natus Medical Inc.
• Sophysa
• Fuji Systems
• Neuromedex GmbH
• Ark BioSciences Inc.
• SILMAG S.A.
• Spiegelberg GmbH & Co. KG
• Möller Medical GmbH
• Dispomedica GmbH
• IRRAS AB
• Luciole Medical AG
• Dispomedica GmbH
North America was the largest region in the external ventricular drain market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the external ventricular drain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.